Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy
- PMID: 40643710
- DOI: 10.1245/s10434-025-17749-0
Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy
Abstract
Background: Insulin requirements after total or completion pancreatectomy (TP/CP) remain uncertain, complicating postoperative diabetes and nutritional care. This study uncovers key factors influencing these requirements.
Methods: This retrospective study included 53 patients who underwent TP/CP between July 2005 and October 2023. Data on the perioperative clinical, diabetic, and nutritional factors were also collected. Multivariable analyses were performed for the insulin-to-glucose ratio (IGR) on postoperative days (POD) 1 and 2 and the insulin dose during long-term follow-up.
Results: The median insulin dose and IGR on POD 1 and 2 were 47 units/day and 0.26 units/g, respectively. The median insulin dose at discharge was 18 U/day, which increased to 23 U/day during follow-up. High preoperative HbA1c levels (odds ratio [OR], 8.68) and long operation time (OR 7.26) were determinants of high IGR. Although long-standing diabetes mellitus before surgery did not correlate with IGR, it was the sole predictor of high insulin requirement (OR 8.09) during follow-up (30 vs. 20 units/day). This resulted in improved nutritional status, as reflected by changes in body weight (P < 0.001) and nutritional scores (CONUT score, P = 0.041; geriatric nutritional risk index, P = 0.002). In contrast, patients without preoperative diabetes tended to require low insulin doses during follow-up, leading to poor diabetic control and worsening of nutritional status, as reflected in the CONUT score (P = 0.013).
Conclusions: Adjusting insulin doses and controlling diabetes can be more challenging when performing TP/CP in patients without diabetes than in patients with long-standing diabetes mellitus. Careful management is required for these patients to achieve better nutritional status.
Keywords: Completion pancreatectomy; Diabetes mellites; Late complication; Long-standing DM; Total pancreatectomy.
© 2025. Society of Surgical Oncology.
Conflict of interest statement
Disclosure: The authors have no conflict of interest to declare.
Similar articles
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?Clin Orthop Relat Res. 2025 Jun 26;483(9):1680-95. doi: 10.1097/CORR.0000000000003599. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 40569278
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2. Cochrane Database Syst Rev. 2013. PMID: 24234875 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
Cited by
-
ASO Author Reflections: Diabetic and Nutritional Management After Total or Completion Pancreatectomy: Current Status and Future Perspectives.Ann Surg Oncol. 2025 Jul 19. doi: 10.1245/s10434-025-17885-7. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40684015 No abstract available.
References
-
- Griffin JF, Poruk KE, Wolfgang CL. Is it time to expand the role of total pancreatectomy for IPMN? Dig Surg. 2016;33(4):335–42. - PubMed
-
- Almond M, Roberts KJ, Hodson J, et al. Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB (Oxford). 2015;17(5):416–21. - PubMed
-
- Rangelova E, Wefer A, Persson S, et al. Surgery improves survival after neoadjuvant therapy for borderline and locally advanced pancreatic cancer: a single institution experience. Ann Surg. 2021;273(3):579–86. - PubMed
-
- Stoop TF, Ateeb Z, Ghorbani P, et al. Surgical outcomes after total pancreatectomy: a high-volume center experience. Ann Surg Oncol. 2021;28(3):1543–51. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous